Author:
Godon C,Proffitt J,Dastugue N,Lafage-Pochitaloff M,Mozziconacci M-J,Talmant P,Hackbarth M,Bataille R,Avet-Loiseau H
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference15 articles.
1. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A . The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial Blood 1998 92: 2322–2333
2. Rowe D, Cotterill SJ, Ross FM, Bunyan DJ, Vickers SJ, Bryon J, McMullan DJ, Griffiths MJ, Reilly JT, Vandenberghe EA, Wilson G, Watmore AE, Bown NP . Cytogenetically cryptic AML1-ETO and CBFB-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia Br J Haematol 2000 111: 1051–1056
3. Langabeer SE, Walker H, Rogers JR, Burnett AK, Wheatley K, Swirsky D, Goldstone AH, Linch DC . Incidence of AML1-ETO fusion transcripts in patients entered into the MRC AML trials Br J Haematol 1997 99: 925–928
4. Sarriera JE, Albitar M, Estrov Z, Gidel C, Aboul-Nasr R, Manshouri T, Kornblau S, Chang KS, Kantarjian H, Estey E . Comparison of outcome in acute myelogenous leukemia patients with translocation t(8;21) found by standard cytogenetic analysis and patients with AML1-ETO fusion transcript found only by PCR testing Leukemia 2001 15: 57–61
5. Bloomfield CD, Lawrence D, Byrd JC, Carroll A, Pettenati MJ, Tantravahi R, Patil SR, Davey FR, Berg DT, Schiffer CA, Arthur DC, Mayer RJ . Frequency of prolonged remission duration after high dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype Cancer Res 1998 58: 4173–4179
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献